Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose vs Low-dose Interferon Beta 1-a in Moderate to Severe COVID-19
NCT04521400Phase 2Unknown
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Aug 2020
- Primary completion
- Sep 2020
- Modality
- Cytokines & Interferons
01
Overview
A Phase 2 trial of interferon beta-1a in coronavirus disease 2019 (COVID-19), sponsored by Shahid Beheshti University of Medical Sciences. Status: unknown.
02
Drugs
interferon beta-1a
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04521400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04521400.